-       Report 
- January 2025
-  82 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- December 2024
-  70 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- December 2024
-  82 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2024
-  188 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- July 2024
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
           -       Report 
- April 2024
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- April 2024
-  185 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- October 2023
-  172 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- July 2024
-  150 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- February 2024
-  120 Pages 
- Asia Pacific 
   From       €3542EUR$3,960USD£3,116GBP 
      €4428EUR$4,950USD£3,895GBP 
          -       Report 
- February 2022
-  32 Pages 
- Global 
   From       €1789EUR$2,000USD£1,574GBP 
          -       Report 
- July 2024
-  137 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- May 2024
-  170 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- March 2024
-  175 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- March 2024
-  177 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- November 2021
-  120 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
       
       The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders    Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less   Read more